5:37 PM
 | 
Mar 07, 2013
 |  BC Extra  |  Financial News

Pharmacyclics planning follow-on

Pharmacyclics Inc. (NASDAQ:PCYC) said late Thursday it plans to sell 2.2 million shares in a follow-on underwritten by JPMorgan. If sold at Pharmacyclics' Thursday close...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >